Showing results (401-410 of 4,039) with videos related to
Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|October 30, 2024
A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record SystemLamia Y Haque, Janet P Tate, Michael Chew, et al.Pharmacoepidemiology and Drug Safety|October 28, 2024
The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposalsDonna R Rivera, Joy C Eckert, Carla Rodriguez-Watson, et al.Pharmacoepidemiology and Drug Safety|October 24, 2024
Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort StudyAvery Shuei-He Yang, Leila Djebarri, Chaw Ning Lee, et al.Pharmacoepidemiology and Drug Safety|October 24, 2024
Core Concepts in Pharmacoepidemiology: Time-To-Event Analysis Approaches in PharmacoepidemiologyGerd Rippin, Shahrzad Salmasi, Héctor Sanz, et al.Pharmacoepidemiology and Drug Safety|September 6, 2024
Detecting and Dating Early Non-live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health RegistriesHedvig Nordeng, Angela Lupattelli, Hilde M Engjom, et al.Pharmacoepidemiology and Drug Safety|September 6, 2024
Association Between Influenza Vaccination and Acute Kidney Injury Among the Elderly: A Self-Controlled Case SeriesHaerin Cho, Eunsun Lim, Hee-Jin Kim, et al.Pharmacoepidemiology and Drug Safety|September 10, 2024
An Emulated Target Trial Case Study of Real-World Overall Survival With Second-Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian CancerJessica A Perhanidis, Linda Kalilani, Nicole M Zimmerman, et al.Pharmacoepidemiology and Drug Safety|February 15, 2025
Adapting the European Concerted Action on Congenital Anomalies and Twins (EUROCAT) Guide 1.5 for Use in Post-Authorisation Safety Studies Using US DataSarah Ruth Hoffman, Geetika Kalloo, Stephan Lanes, et al.Pharmacoepidemiology and Drug Safety|February 17, 2025
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer PopulationJames S Heyward, Jodi B Segal, Hemalkumar B Mehta, et al.Pharmacoepidemiology and Drug Safety|August 5, 2024
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)Xuya Xiao, G Caleb Alexander, Hemalkumar B MehtaPageof 404